Find a Tender
complete
Official procurement procedure
HLA TISSUE TYPING FOR BONE MARROW VOLUNTEER DONORS PERFORMED BY 3RD PARTY SUPPLIER
Blood-testing reagents
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust): "HLA TISSUE TYPING FOR BONE MARROW VOLUNTEER DONORS PERFORMED BY 3RD PARTY SUPPLIER". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
1.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 443 active published awards; 365 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published2 Jul 2024, 13:24 BST | Last source update2 Jul 2024, 13:24 BST | Recurring procurementNot published |
ClassificationBlood-testing reagents | ||
Delivery area | ||
OCIDocds-h6vhtk-029a1f | ||
What is being bought
The unrelated bone marrow volunteer donors are recruited at blood session and added to the donor panel, the HLA tissue typing is outsourced to a 3rd party supplier. The Tissue typing is critical to the matching of a donor with a patient and hence the provision of a life-saving stem cell transplant. The service provided is HLA tissue typing for all relevant genetic markers to facilitate a stem cell transplant. The supplier provides CCR5 testing CCR5 testing (mutation called delta 32 that is protective against the common HIV virus strains)
What changed
From the official release history
- Official notice release published
2 Jul 2024, 13:24 BST - Status changed to complete
10 Mar 2021, 09:16 GMT - Official notice release published
10 Mar 2021, 09:16 GMT - Buyer information updated
10 Mar 2021, 09:16 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe unrelated bone marrow volunteer donors are recruited at blood session and added to the donor panel, the HLA tissue typing is outsourced to a 3rd party supplier. The Tissue typing is critical to the matching of a donor with a patient and hence the provision of a life-saving stem cell transplant. The service provided is HLA tissue typing for all relevant genetic markers to facilitate a stem cell transplant. The supplier provides CCR5 testing CCR5 testing (mutation called delta 32 that is protective against the common HIV virus strains)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
2 Jul 2024, 13:24 BST - Award active
Not published · Not published - Contract active
Signed 9 Mar 2021, 00:00 GMT · £140,000
Commercial outcome and competition
Awards Histogenetics Not published · Not published · active |
Contracts Contract £140,000 · signed 9 Mar 2021, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 1 (lot 1) smeBids: 0 (lot 1) |
Buyer and organisations in this procedure
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Contracting authority GB-FTS-109Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleAs an international stem cell registry the WBMDR has been working hard to maintain the provision of stem cell products to facilitate transplants locally and globally during this COVID-19 pandemic. We have experienced many challenges such as reducing donor exposure, international flight quarantine, grounding of commercial flights, using freight and cargo flight to transport stem cells (HTA full knowledge), transportation of cryopreserved stem cells to name but a few. Unfortunately, reacting to these changes and implementing safe and viable alternative processes has taken up a great deal of time and the fact that we are working with European registries on this tender process, who have themselves experienced the same COVID related issues, has meant that progress has been limited. This is therefore an interim arrangement whilst a re-tendering process is undertaken. |